|
|
|
By Aditi Shivarkar, insightSLICE | The KRAS gene, a crucial component of cell signaling pathways involved in cell growth and division, is frequently mutated in various cancers. By targeting the gene, KRAS inhibitors aim to block the aberrant signaling that promotes cancer cell proliferation. Amgen's sotorasib became the first approved KRAS inhibitor, opening up an exciting field. |
|
|
|
|
| Approaches To Establishing A Perfusion Mimic Process | Application Note | Sartorius | We demonstrate how high-throughput perfusion mimic processes can be achieved in microbioreactors with good consistency among the replicates and with sustained cell viability and protein production. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|